leukemia Archives - Medical Conferences

Transformation of foetal haematopoietic stem and progenitor cells in the background of trisomy 21

Presented By

Dr Sophia Gialesaki, Hannover Medical School, Germany

Conference

EHA 2019

9 August, 2019 23:00

Unmutated IGHV as predictive factor for venetoclax/obinutuzumab benefit in frontline CLL

Presented By

Dr Eugen Tausch, University of Ulm, Germany

Trial

CLL14

Conference

EHA 2019

9 August, 2019 22:38

CAR-T cell therapy in ALL as breakthrough advance

Presented By

Prof. Mohamad Mohty, Saint-Antoine Hospital and University Pierre & Marie Curie, France

Trial

Phase 2, ELIANA

Conference

EHA 2019

9 August, 2019 21:36

Exciting survival data for ibrutinib vs placebo in treatment-naïve, early-stage CLL

Presented By

Dr Petra Langerbeins, University of Cologne, Germany

Trial

Phase 3, CLL12

Conference

EHA 2019

9 August, 2019 16:26

ASCEND study: Acalabrutinib improves progression-free survival in relapsed/refractory CLL

Presented By

Dr Paolo Ghia, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, ASCEND

Conference

EHA 2019

9 August, 2019 15:28

Asciminib plus imatinib in patients with heavily pre-treated chronic myeloid leukaemia

Presented By

Prof. Jorge Cortes, University of Texas MD Anderson Cancer Center, USA

Trial

Phase 1

Conference

EHA 2020

9 August, 2019 12:22

Guadecitabine vs treatment of choice in AML

Presented By

Prof. Pierre Fenaux, Hôpital Saint-Louis, France

Trial

Phase 3, ASTRAL-1

Conference

EHA 2019

9 August, 2019 09:25

Venetoclax-obinutuzumab combination elicits high response rates in CLL

Presented By

Dr Kirsten Fischer, University of Cologne, Germany

Trial

Phase 3, CLL14

Conference

EHA 2019

9 June, 2019 23:28